|
| NEWSLETTER November 2020 |
|
| News |
|
|
|
|
Artificial Intelligence to predict the evolution of patients with COVID-19
The Hospital Clínic de Barcelona and BSC work together to create a model based on artificial intelligence that helps doctors predict the evolution of patients with COVID-19 and those responsible for the centres to plan their internal organization in the event of a new wave. The project is part of the Plan for the Promotion of Language Technologies of the Secretary for Digitalisation and Artificial Intelligence.
|
|
|
|
An international competition evaluates AI tools to help in the diagnosis of cancer cases
The CANTEMIST international competition has shown the capacity of the new generation of artificial intelligence (AI) tools to extract and catalog clinical information to help doctors carry out more precise diagnostics of cancer cases. The systems generated during this competition could facilitate the automatization of tumor biobanks, as well as clinical reports of tumor pathology.
|
|
|
|
Improving European healthcare through cell-based interceptive medicine
The LifeTime initiative, including BSC, has developed a strategy to advance personalised treatment for five major disease classes: cancer, neurological-, infectious-, chronic inflammatory- and cardiovascular diseases. The aim is a new age of personalised, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment.
|
|
|
|
|
|
|
Timeline of early eukaryotic evolution unveiled
A collaborative study between the groups of Toni Gabaldón, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) and BSC, and Berend Snel at the University of Utrecht, has concluded that the first cell to incorporate a mitochondrion (considered the key step to the increased complexity of eukaryotic cells) already presented eukaryote-like complexity in structure and functions.
|
|
|
|
|
|
|
BSC and the Barcelona City Council expand their collaboration
The collaboration is oriented to carry out citizen science projects that need a high capacity of processing from municipal data; promote scientific dissemination; participate in citizen science projects, and facilitate the exchange and circulation of research staff in citizen science projects and city challenges.
|
|
|
|
Alfonso Valencia, named as the IMI scientific committee vice-chair
The director of the Life Sciences department at BSC, Alfonso Valencia, is now the Innovative Medicines Initiative (IMI) scientific committee’s vice-chair. Valencia has been unanimously elected, as has Isabelle Bekeredjian-Ding, who will be the chair. The IMI is the largest public-private initiative in the world, which aims to improve biomedical research in Europe to achieve safer and more effective medicines in shorter times.
|
|
|
|
|
|
|
The Catalan Minister Meritxell Budó visits BSC
The Minister of the Presidency of the Catalan Government, Meritxell Budó, visited BSC to see first-hand the research that is being carried out. Budó was able to learn about the main projects underway in the centre, such as the development of a new European-made chip. She also saw the progress of the works of the new building that will be the headquarters of BSC, and visited the space under construction that will house the future MareNostrum 5 supercomputer.
|
|
|
|
| Coming up |
|
| 09 |
NOV 2020 |
SC 20
Location: Online |
|
|
|
|
|
|
|
|
|
|
|
|
| ©BSC-CNS, 2024 - Plaça Eusebi Güell, 1-3. 08034 Barcelona (Spain) - Legal Notice |
   |
|
